IONS Ionis Pharmaceuticals, Inc.

44.16USD+0.36%Mkt Cap: 7.34B $P/E: —

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemi…

Key Statistics

Company
Market Cap7.34B USD
Enterprise Value7.40B USD
Revenue (TTM)874.09M USD
Gross Profit927.80M USD
Net Income (TTM)-381.39M USD
Revenue/Share5.36 USD
Last Price44.16 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.5K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-39.56
PEG27.33
EV/EBITDA-12.77
EV/Revenue8.46
P/S8.37
P/B16.57
EPS (TTM)-3.48
EPS (Forward)-1.11
52W Range
42.633% of range86.74
52W High86.74 USD
52W Low42.63 USD
Profitability
Gross Margin98.31%
Oper. Margin-38.18%
EBITDA Margin-66.30%
Profit Margin-40.41%
ROE-77.98%
ROA-10.82%
Growth
Revenue Growth-40.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-268.58M USD
CapEx (TTM)57.08M USD
FCF Margin-39.67%
FCF Yield-4.73%
Net Debt86.67M USD
Net Debt/EBITDA-0.15
Balance Sheet
Debt/Equity4.22
Current Ratio7.89
Quick Ratio6.85
Book Value/Sh2.65 USD
Cash/Share12.65 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)83.64 USD
Upside (mean)+89.4%
Target Range54.00 USD – 105.00 USD
54.00+89.4% to mean105.00
# Analysts22
Ownership
Shares Out.166.18M
Float164.82M
Insiders0.61%
Institutions110.37%
Short Interest
Short Ratio6.6d
Short % Float16.65%
Short % Out.12.57%
Shares Short20.89M
Short (prev mo.)20.91M
Technical
SMA 5053.41 (-17.3%)
SMA 20070.05 (-37.0%)
Beta0.38
S&P 52W Chg16.45%
Avg Vol (30d)3.58M
Avg Vol (10d)3.58M
Technical Indicators
RSI (14)32.4
MACD-3.3537
MACD Signal-3.5023
MACD Hist.+0.1486
BB Upper56.53 USD
BB Middle47.08 USD
BB Lower37.63 USD
BB Width40.15%
ATR (14)1.990 USD
Vol Ratio (20d)0.65x